BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16341121)

  • 1. High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.
    Pierantoni GM; Rinaldo C; Esposito F; Mottolese M; Soddu S; Fusco A
    Cell Death Differ; 2006 Sep; 13(9):1554-63. PubMed ID: 16341121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.
    Esposito F; Tornincasa M; Chieffi P; De Martino I; Pierantoni GM; Fusco A
    Cancer Res; 2010 Jul; 70(13):5379-88. PubMed ID: 20530667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress.
    Speidel D; Helmbold H; Deppert W
    Oncogene; 2006 Feb; 25(6):940-53. PubMed ID: 16247471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
    Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
    Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
    Magrini R; Russo D; Fronza G; Inga A; Menichini P
    J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.
    Esposito F; Tornincasa M; Federico A; Chiappetta G; Pierantoni GM; Fusco A
    Cell Death Dis; 2012 Aug; 3(8):e383. PubMed ID: 22932725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context.
    Valentino T; Palmieri D; Vitiello M; Pierantoni GM; Fusco A; Fedele M
    Cell Death Dis; 2013 Dec; 4(12):e963. PubMed ID: 24336083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis.
    McKay BC; Ljungman M; Rainbow AJ
    Oncogene; 1998 Aug; 17(5):545-55. PubMed ID: 9704920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
    Latonen L; Taya Y; Laiho M
    Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apoptotic and transcriptional transactivation activities of p53 can be dissociated.
    Bissonnette N; Wasylyk B; Hunting DJ
    Biochem Cell Biol; 1997; 75(4):351-8. PubMed ID: 9493957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival.
    Sadagopan S; Veettil MV; Chakraborty S; Sharma-Walia N; Paudel N; Bottero V; Chandran B
    Oncogene; 2012 Nov; 31(46):4835-47. PubMed ID: 22266868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
    Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
    Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
    Ndoye A; Dolivet G; Høgset A; Leroux A; Fifre A; Erbacher P; Berg K; Behr JP; Guillemin F; Merlin JL
    Mol Ther; 2006 Jun; 13(6):1156-62. PubMed ID: 16564229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.